Janssen Pharmaceuticals, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
This is a notice published in the Federal Register by Justice Department, Drug Enforcement Administration. Notices communicate information, guidance, or policy interpretations but may not create new binding obligations.
This document is classified as a notice. It may or may not create enforceable regulatory obligations depending on its specific content.
Notice of application.
Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before February 17, 2026. Such persons may also file a written request for a hearing on the application on or before February 17, 2026.
| Document Number | 2025-23467 |
| FR Citation | 90 FR 59583 |
| Type | Notice |
| Published | Dec 19, 2025 |
| Effective Date | - |
| RIN | - |
| Docket ID | Docket No. DEA-1635 |
| Pages | 59583–59583 (1 pages) |
| Text Fetched | No |
| Part | Name | Agency |
|---|---|---|
| No linked CFR parts | ||
| Type | Proposed | Final | Method | Conf |
|---|---|---|---|---|
| No paired documents | ||||
The full text for this document hasn't been fetched yet. The system will automatically retrieve it during the next processing cycle.